Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
At Cedars-Sinai Medical Center, the investigators have developed a novel curriculum for a 6-week psycho-educationally-based, cognitive behavioral program to help patients with subjective cognitive complaints after cancer treatment, titled Emerging from the Hazeâ„¢ (Haze). Each series meets once a week for 2-2.5 hours for 6 weeks.
The objective of this study is to quantify the impact of a trainee-taught Emerging from the Haze course on gynecologic cancer survivors' self-report of cognitive changes based on the change of FACT-Cog score.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Emerging from the Haze class | Experimental | A 6-week psycho-educationally-based, cognitive behavioral program to help patients with subjective cognitive complaints after cancer treatment, titled Emerging from the Hazeâ„¢ (Haze). Each series meets once a week for 2-2.5 hours for 6 weeks. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Emerging from the Haze class | Behavioral | A 6-week class designed to combat chemotherapy-induced cognitive dysfunction. Patients will report symptoms at 6 months and 1 year after the end of their Haze class. |
| Measure | Description | Time Frame |
|---|---|---|
| The Functional Assessment of Cancer Therapy- Cognition (FACT-Cog) Survey | Measure the change in score from baseline to each of three time points: last day of class (6 weeks), 6 months, and 1 year after class | First day of class (baseline), last day of class (6 weeks), 6 months and 1 year after class |
| Measure | Description | Time Frame |
|---|---|---|
| Patient Reported Outcomes Measurement Information System (PROMIS) - Cognition and General Concerns Survey | Measure the change in score from baseline to each of three time points: last day of class (6 weeks), 6 months, and 1 year after class | First day of class (baseline), last day of class (6 weeks), 6 months and 1 year after class |
| Measure | Description | Time Frame |
|---|---|---|
| Comparison of trainee-taught vs non-trainee taught class | To compare the impact of a trainee-taught Emerging from the Haze course on gynecologic cancer survivors' self report of cognitive changes based on change of the FACT-Cog compared to the impact of an ongoing non-trainee-taught Emerging from the Haze course on breast cancer survivors' self report of cognitive changes based on the change in FACT-Cog score from first day of class (baseline) to last day of class (6 weeks) in these two groups |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Arash Asher, MD | Cedars-Sinai Medical Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Cedars Sinai Medical Center | Los Angeles | California | 90048 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D005833 | Genital Neoplasms, Female |
| D003072 | Cognition Disorders |
| ID | Term |
|---|---|
| D014565 | Urogenital Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D005831 | Genital Diseases, Female |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| UCLA Loneliness Scale Survey |
Measure the change in score from baseline to each of three time points: last day of class (6 weeks), 6 months, and 1 year after class |
| First day of class (baseline), last day of class (6 weeks), 6 months and 1 year after class |
| First day of class (baseline), last day of class (6 weeks) |
| D052776 |
| Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D000091662 | Genital Diseases |
| D019965 | Neurocognitive Disorders |
| D001523 | Mental Disorders |